Natural history and outcomes in drug-induced autoimmune hepatitis

Hepatology Research

Volumn 46, Issue 3, 2016, Pages E79-E88

  Yeong, Tian T ^a   Lim, Kok H J ^b   Goubet, Stephanie ^b   Parnell, Nick ^b   Verma, Sumita ^a,b  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b Brighton and Sussex University Hospitals   (United Kingdom)

Author keywords

Drug induced liver injury; Herbal remedies; Nitrofurantoin; Statins

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; CYCLOSPORIN; DICLOFENAC; ECHINACEA EXTRACT; GLOBULIN; IMMUNOGLOBULIN G; MERCAPTOPURINE; MYCOPHENOLIC ACID; NITROFURANTOIN; PREDNISOLONE; SIMVASTATIN; VALERIAN;

ADULT; AGE; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED AUTOIMMUNE HEPATITIS; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOBULIN BLOOD LEVEL; HEPATOBILIARY PARAMETERS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; OUTCOME ASSESSMENT; PORTAL INFLAMMATION; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL; TOXIC HEPATITIS; TREATMENT DURATION; VERY ELDERLY;

EID: 84930333410     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12532     Document Type: Article

References (34)

1. Heneghan MA, Yeoman AD, Verma S et al. Autoimmune hepatitis. Lancet 2013 382: 1433-44.
2. Manns MP, Czaja AJ, Gorham JD et al. American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology 2010 51: 2193-213.
3. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996 110: 848-57.
4. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005 42(1): 53-62.
5. Verma S, Gunuwan B, Mendler M et al. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004 99: 1510-6.
6. Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 2007 46: 1828-35.
7. Heurgué A, Bernard-Chabert B, Diebold M et al. Drug-induced autoimmune hepatitis: a frequent disorder. Gut 2007 56(Suppl III): A271.
8. Björnsson E, Talwalkar J, Treeprasertsuk S et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010 51: 2040-8.
9. Licata A, Butera G, Macaluso FS et al. Clinical features and outcomes of patients with drug-induced autoimmune hepatitis. Dig Liver Dis 2012 44(Suppl 1): S12.
10. Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. J Hepatol 2011 55: 747-9.
11. Sugimoto K, Ito T, Yamamoto N et al. Seven cases of autoimmune hepatitis that developed after drug-induced liver injury. Hepatology 2011 54: 1892-3.
12. Björnsson E, Davidsdottir L. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice. J Hepatol 2009 50: 511-7.
13. Lucena MI, Kaplowitz N, Hallal H et al. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis. J Hepatol 2011 55: 820-7.
14. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999 31: 929-38.
15. Danan G, Benichou C. Causality assessment of adverse reactions to drugs--1. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993 46: 1323-30.
16. Björnsson ES, Bergmann OM, Björnsson HK et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013 144: 1419-25.
17. Appleyard S, Saraswati R, Gorard DA. Autoimmune hepatitis triggered by nitrofurantoin: a case series. J Med Case Rep 2010 4: 311.
18. Sakaan SA, Twilla JD, Usery JB et al. Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication. South Med J 2014 107: 107-13.
19. Sharp JR, Ishak KG, Zimmerman HJ. Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin. Ann Intern Med 1980 92: 14-9.
20. Russo MW, Hoofnagle JH, Gu J et al. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network. Hepatology 2014 60: 679-86.
21. Alla V, Abraham J, Siddiqui J et al. Autoimmune hepatitis triggered by statins. L Clin Gastroenterol 2006 40: 757-61.
22. Castiella A, Fernandez J, Zapate E. Autoimmune hepatitis after treatment with fluvastatin. Liv Int 2007 27: 592.
23. Unzueta A, Vargas HE. Nonsteroidal anti-inflammatory drug-induced hepatoxicity. Clin Liver Dis 2013 17: 643-56.
24. Scully LJ, Clarke D, Barr RJ. Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis. Dig Dis Sci 1993 38: 744-51.
25. MacGregor FB, Abernethy VE, Dahabra S et al. Hepatotoxicity of herbal remedies. BMJ 1989 299: 1156-7.
26. Cohen DL, Del Toro Y. A case of valerian-associated hepatotoxicity. J Clin Gastroenterol 2008 42: 961-2.
27. Kocman O, Hulagu S, Senturk O. Echinacea-induced severe acute hepatitis with features of cholestatic autoimmune hepatitis. Eur J Intern Med 2008 19: 148.
28. Lawrenson JA, Walls T, Day AS. Echinacea-induced acute liver failure in a child. J Paediatr Child Health 2014 50: 841.
29. Suzuki A, Brunt EM, Kleiner DE et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011 54: 931-9.
30. Castiella A, Zapara Lucena E. Hepatotoxicity with autoimmune features. Analysis of the cases included in the Spanish DILI registry. Basic Clin Pharmacol Toxicol 2011; 109 (Suppl 3): 53 (abstract)
31. Andrade RJ, Lucena MI, Kaplowitz N et al. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology 2006 44: 1581-8.
32. Navarro VJ, Barnhart H, Bonkovsky HL et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 2014 60: 1399-408.
33. Kennedy J. Herb and supplement use in the US adult population. Clin Ther 2005 27: 1847-58.
34. Shepherd C. Sleep disorders. Liver damage warning with insomnia remedy. BMJ 1993 306: 1477.